Clinical trial
Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in…
NCT00433836 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00433836 |
|---|---|
| Title | Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure |
| Official title | A Multicenter, Randomized, Double-blind, Parallel-group, Evaluation of 12 Weeks of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children 6 to 17 Years of Age With Hypertension |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan, Enalapril |
| Enrollment | 300 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Feb 12, 2007 |
| Last update posted | May 19, 2011 |
| Countries | Belgium, France, Germany, Hungary, India, Italy, Poland, Slovakia, Sweden, Turkey (Türkiye), United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: